BUSINESS4 years ago
Revive Therapeutics Ltd (OTCMKTS:RVVTF) Submits IND application for Bucillamine to the FDA for Evaluation as a Potential Treatment for COVID-19
It seems like Revive Therapeutics Ltd (OTCMKTS:RVVTF) has promising progress in its operations. The company’s plans for initiating a Phase 3 study on Bucillamine are rolling...